Companies: 10,795·Total market cap: $144.5T
Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

AGNPFOTCHealthcare● Active
$0.44
+$0.01(+1.36%)
Market Cap$1541620
P/E Ratio—
52W High$0.713
52W Low$0.23
Overview

Algernon Pharmaceuticals Inc. (AGNPF) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · AGNPF · as of 2026-06-15

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-082024-082023-082022-082021-08
Operating Activities
Net Income($0.00B)($0.00B)($0.01B)($0.01B)($0.01B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital$0.00B($0.00B)$0.00B$0.00B($0.00B)
Net Cash from Operations($0.00B)($0.00B)($0.00B)($0.00B)($0.01B)
Investing Activities
Capital Expenditure($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Purchases of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing$0.00B$0.00B($0.00B)($0.00B)($0.00B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Financing$0.00B$0.00B$0.00B$0.00B$0.00B
Free Cash Flow
Free Cash Flow($0.00B)($0.00B)($0.00B)($0.00B)($0.01B)
FCF Margin %(computed)—————

Data source: Financial Modeling Prep · Last updated: 2026-06-15 · CAD · B

SEC 10-K filings →SEC 10-Q filings →

Explore more Algernon Pharmaceuticals Inc. data

Revenue History
Quarterly & annual revenue trends
Earnings Reports
EPS beats, misses & upcoming dates
P/E Ratio
Historical price-to-earnings
Dividends
Dividend history & yield
Market Cap
Historical market cap & rank
Analyst Forecast
Consensus, price targets & estimates

About Algernon Pharmaceuticals Inc. (AGNPF) Cash Flow Statement

Algernon Pharmaceuticals Inc. generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).

Frequently asked questions

AGNPF · 4 questions

Algernon Pharmaceuticals Inc. generated free cash flow of ($0.00B) for 2025, up 58.6% year-over-year.

AGNPF free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15